PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 15, 2026Journal of the American Chemical Society5 citationsOpen Access

An Amino-Acid-Derived Metal–Organic Framework with Large Pores for Unspecific Enantioseparation

View Full Paper
XMXiaoyu MaMWMengdi WangWLWenxuan Li

Key Points

  • The research aims to create a highly effective metal-organic framework for the selective separation of enantiomers in pharmaceuticals.
  • Development of a homochiral metal-organic framework using phenylalanine-derived ligands and zinc ions.
  • Characterization of the MOF's large chiral cavity and its binding properties.
  • Evaluation of the MOF's performance in separating various chiral compounds through adsorption experiments.
  • The MOF features a chiral cavity size of 2.2 × 3.1 nm with 42 chiral residues.
  • Demonstrated effective separation of bulky substrate enantiomers and structurally complex chiral pharmaceuticals.
  • The framework can be recovered and reused without loss of performance.

Abstract

The selective separation of enantiomers is critical in pharmaceutical production, while conventional chiral sorbents always suffer from the trade-off between selectivity and the substrate scope. Herein, inspired by a natural unspecific peroxygenase with large protein channels, we developed a homochiral metal-organic framework (MOF) constructed from flexible phenylalanine-derived ligands and zinc ions. This MOF features a giant chiral cavity with a size of 2.2 × 3.1 nm, decorated with 42 chiral phenylalanine residues, which serves as a solid sorbent for the highly enantioselective adsorption and separation of diverse chiral compounds, including aromatic epoxides, β-nitroalcohols, mandelate derivatives, secondary alcohols, indolin-3-ones, α-methylbenzylamine, and limonene. Most importantly, benefiting from its large pores, the MOF demonstrates versatile utility in resolving the enantiomers of extraordinarily bulky substrates and structurally complex chiral pharmaceuticals, which can be further processed into a polymer matrix for membrane separation, enabling an integrated, chromatography-free route from batch-scale adsorption and separation. This material can be readily recovered and reused without an apparent loss of performance. Adsorption experiments and theoretical calculations reveal that the chiral recognition and separation originate from the distinct binding affinity of enantiomers within the MOF's chiral pore environment, presenting a scalable platform for process-intensified chiral separations.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Ma et al. (2026) studied this question.

synapsesocial.com/papers/69b64c33b42794e3e660da14https://doi.org/10.1021/jacs.5c22595
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Engineering MOF-Assembled Nanochannels for Enantioselective Detection and Separation of Chiral Drugs2026 · 3 citations
  2. 2Chiral Metal–Organic Framework Nanostructures for Chiral Channel-Dependent Enantioselective Sensing2024 · 7 citations
  3. 3Enantiopure‐Grafted Metal–Organic Framework for the Separation of the Enantiomers of Baclofen2025
  4. 4Robust Homochiral Polycrystalline Metal–Organic Framework Membranes for High-Performance Enantioselective Separation2024 · 65 citations
  5. 5High Performance Enantioselective Separation Facilitated by Charged Chiral Covalent Organic Framework Membrane2026 · 1 citations